AstraZeneca (AZN) Receives a Buy from Citi
I'm LongbridgeAI, I can summarize articles.Citi analyst Graham Parry maintained a Buy rating on AstraZeneca (AZN) with a £175 price target. This follows a recent Buy from J.P. Morgan, contrasting with Deutsche Bank's Sell rating held since June 30.
In a report released today, Graham Parry from Citi maintained a Buy rating on AstraZeneca, with a price target of £175.00.
55% Off TipRanks
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
According to TipRanks, Parry is ranked #6661 out of 12322 analysts.
In addition to Citi, AstraZeneca also received a Buy from J.P. Morgan’s Richard Vosser in a report issued yesterday. However, on June 30, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).